GlaxoSmithKline Holdings (Americas) | tax violations | 2006 | IRS | $3,400,000,000 |
GlaxoSmithKline LLC | off-label or unapproved promotion of medical products | 2012 | FDA | $3,000,000,000 |
GlaxoSmithKline | drug or medical equipment safety violation | 2010 | private lawsuit-federal | $770,000,000 |
SB Pharmco Puerto Rico Inc. | drug or medical equipment safety violation | 2010 | FDA | $750,000,000 |
GlaxoSmithKline | off-label or unapproved promotion of medical products | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $477,792,391 |
GlaxoSmithKline | price-fixing or anti-competitive practices | 2004 | private lawsuit-federal | $175,000,000 |
SB Pharmco Puerto Rico Inc. | drug or medical equipment safety violation | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $163,560,000 |
GlaxoSmithKline | False Claims Act and related | 2005 | DOJ_CIVIL | $150,000,000 |
GlaxoSmithKline PLC | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $150,000,000 |
GlaxoSmithKline, LLC | kickbacks and bribery | 2014 | MULTI-AG | $105,000,000 |
GlaxoSmithKline PLC | price-fixing or anti-competitive practices | 2005 | private lawsuit-federal | $100,000,000 |
GlaxoSmithKline PLC | price-fixing or anti-competitive practices | 2004 | private lawsuit-federal | $92,000,000 |
GlaxoSmithKline LLC | drug or medical equipment safety violation | 2012 | MULTI-AG | $90,000,000 |
GlaxoSmithKline | price-fixing or anti-competitive practices | 2005 | private lawsuit-federal | $75,000,000 |
GlaxoSmithKline | price-fixing or anti-competitive practices | 2006 | MULTI-AG | $70,000,000 |
GlaxoSmithKline PLC | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $70,000,000 |
GlaxoSmithKline PLC | price-fixing or anti-competitive practices | 2005 | private lawsuit-federal | $65,000,000 |
GlaxoSmithKline | drug or medical equipment safety violation | 2006 | private lawsuit-state | $63,833,148 |
GlaxoSmithKline LLC | False Claims Act and related | 2019 | IL-AG | $54,653,931 |
GlaxoSmithKline PLC | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $49,000,000 |
SmithKline Beecham | False Claims Act and related | 2003 | DOJ_CIVIL | $47,000,000 |
GlaxoSmithKline, LLC | drug or medical equipment safety violation | 2011 | MULTI-AG | $40,750,000 |
GlaxoSmithKline | False Claims Act and related | 2003 | MULTI-AG | $40,000,000 |
GlaxoSmithKline | drug or medical equipment safety violation | 2008 | private lawsuit-federal | $40,000,000 |
GlaxoSmithKline PLC | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $35,000,000 |
GlaxoSmithKline | drug or medical equipment safety violation | 2009 | private lawsuit-federal | $28,000,000 |
GlaxoSmithKline PLC | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $21,500,000 |
GlaxoSmithKline plc | kickbacks and bribery | 2016 | SEC | $20,000,000 |
GlaxoSmithKline, LLC | off-label or unapproved promotion of medical products | 2013 | MD-AG | $15,000,000 |
GlaxoSmithKline | price-fixing or anti-competitive practices | 2006 | MULTI-AG | $14,000,000 |
GlaxoSmithKline | False Claims Act and related | 2005 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $10,000,000 |
GlaxoSmithKline | False Claims Act and related | 2012 | LA-AG | $10,000,000 |
SmithKline Beecham Corp. | price-fixing or anti-competitive practices | 2005 | MULTI-AG | $10,000,000 |
GlaxoSmithKline | False Claims Act and related | 2011 | KS-AG | $4,250,000 |
GlaxoSmithKline | off-label or unapproved promotion of medical products | 2010 | KY-AG | $3,700,000 |
GlaxoSmithKline | price-fixing or anti-competitive practices | 2006 | MULTI-AG | $3,500,000 |
GlaxoSmithKline LLC | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
GlaxoSmithKline | False Claims Act and related | 2012 | ID-AG | $2,600,000 |
SmithKline Beecham Corp. | False Claims Act and related | 2007 | TX-AG | $1,400,000 |
GlaxoSmithKline | price-fixing or anti-competitive practices | 2023 | IN-AG | $1,270,000 |
GlaxoSmithKline | off-label or unapproved promotion of medical products | 2009 | KY-AG | $661,860 |
GlaxoSmithKline | False Claims Act and related | 2006 | GA-AG | $418,952 |
Block Drug Company Incorporated | wage and hour violation | 2011 | WHD | $352,773 |
GlaxoSmithKline LLC | hazardous waste violation | 2014 | EPA | $317,550 |
GLAXOSMITHKLINE, LLC | environmental violation | 2014 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $317,550 |
GlaxoSmithKline Vaccines | air pollution violation | 2014 | EPA | $172,900 |
GLAXOSMITHKLINE VACCINES | environmental violation | 2014 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $172,900 |
GLAXO SMITH KLINE | aviation safety violation | 2014 | FAA | $59,500 |
GlaxoSmithKline LLC | environmental violation | 2015 | NY-ENV | $24,200 |
GLAXOSMITHKLINE LLC | environmental violation | 2016 | PA-ENV | $5,259 |